Prenetics Global Limited Class A

Prenetics Global Ltd. is a genomics-driven health sciences company. It operates through following business units; Early Cancer Detection, Prevention, and Treatment Selection & Monitoring. The Early Cancer Detection detects and analyses fragmentation patterns of plasma DNA, providing a non-invasive epigenetics-based means for the detection of a wide variety of cancers, and is expected to provide an accurate and low-cost method for early cancer detection. The Prevention unit seek to build preventive healthcare platform by utilizing science to empower consumers to achieve their personal health goals. Its in-house developed consumer genetic testing product, Circle DNA, offers one of the most comprehensive DNA tests capitalizing in-house developed testing algorithm. The company was founded by Sheng Wu Yeung and Chi Hung Tzang in 2014 and is headquartered in Hong Kong.